These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30553815)

  • 1. Corneal-PAMPA: A novel, non-cell-based assay for prediction of corneal drug permeability.
    Dargó G; Vincze A; Müller J; Kiss HJ; Nagy ZZ; Balogh GT
    Eur J Pharm Sci; 2019 Feb; 128():232-239. PubMed ID: 30553815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuning the predictive capacity of the PAMPA-BBB model.
    Müller J; Esső K; Dargó G; Könczöl Á; Balogh GT
    Eur J Pharm Sci; 2015 Nov; 79():53-60. PubMed ID: 26344358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of various PAMPA models to identify the most discriminating method for the prediction of BBB permeability.
    Mensch J; Melis A; Mackie C; Verreck G; Brewster ME; Augustijns P
    Eur J Pharm Biopharm; 2010 Mar; 74(3):495-502. PubMed ID: 20067834
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Assmus F; Ross A; Fischer H; Seelig J; Seelig A
    Mol Pharm; 2017 Jan; 14(1):284-295. PubMed ID: 27977215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The rise of PAMPA.
    Avdeef A
    Expert Opin Drug Metab Toxicol; 2005 Aug; 1(2):325-42. PubMed ID: 16922646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new PAMPA model using an in-house brain lipid extract for screening the blood-brain barrier permeability of drug candidates.
    Bicker J; Alves G; Fortuna A; Soares-da-Silva P; Falcão A
    Int J Pharm; 2016 Mar; 501(1-2):102-11. PubMed ID: 26836708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin-PAMPA: a new method for fast prediction of skin penetration.
    Sinkó B; Garrigues TM; Balogh GT; Nagy ZK; Tsinman O; Avdeef A; Takács-Novák K
    Eur J Pharm Sci; 2012 Apr; 45(5):698-707. PubMed ID: 22326705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro permeability of poorly aqueous soluble compounds using different solubilizers in the PAMPA assay with liquid chromatography/mass spectrometry detection.
    Liu H; Sabus C; Carter GT; Du C; Avdeef A; Tischler M
    Pharm Res; 2003 Nov; 20(11):1820-6. PubMed ID: 14661927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAMPA--a drug absorption in vitro model. 5. Unstirred water layer in iso-pH mapping assays and pKa(flux)--optimized design (pOD-PAMPA).
    Ruell JA; Tsinman KL; Avdeef A
    Eur J Pharm Sci; 2003 Dec; 20(4-5):393-402. PubMed ID: 14659483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasal-PAMPA: A novel non-cell-based high throughput screening assay for prediction of nasal drug permeability.
    Henriques P; Bicker J; Silva S; Doktorovová S; Fortuna A
    Int J Pharm; 2023 Aug; 643():123252. PubMed ID: 37479103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PAMPA study of the temperature effect on permeability.
    Vizserálek G; Balogh T; Takács-Novák K; Sinkó B
    Eur J Pharm Sci; 2014 Mar; 53():45-9. PubMed ID: 24361474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QSAR study on permeability of hydrophobic compounds with artificial membranes.
    Fujikawa M; Nakao K; Shimizu R; Akamatsu M
    Bioorg Med Chem; 2007 Jun; 15(11):3756-67. PubMed ID: 17418579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physicochemical selectivity of the BBB microenvironment governing passive diffusion--matching with a porcine brain lipid extract artificial membrane permeability model.
    Tsinman O; Tsinman K; Sun N; Avdeef A
    Pharm Res; 2011 Feb; 28(2):337-63. PubMed ID: 20945153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of the Efficacy of Transdermal Penetration Enhancers Through the Use of Human Skin and a Skin Mimic Artificial Membrane.
    Balázs B; Vizserálek G; Berkó S; Budai-Szűcs M; Kelemen A; Sinkó B; Takács-Novák K; Szabó-Révész P; Csányi E
    J Pharm Sci; 2016 Mar; 105(3):1134-40. PubMed ID: 26886318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico model-based exploration of the applicability of parallel artificial membrane permeability assay (PAMPA) to screen chemicals of environmental concern.
    Wang S; Zhang Z; Li D; Illa SE; Li L
    Environ Int; 2022 Dec; 170():107589. PubMed ID: 36274493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Permeation prediction of M100240 using the parallel artificial membrane permeability assay.
    Hwang KK; Martin NE; Jiang L; Zhu C
    J Pharm Pharm Sci; 2003; 6(3):315-20. PubMed ID: 14738711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico prediction of human oral absorption based on QSAR analyses of PAMPA permeability.
    Akamatsu M; Fujikawa M; Nakao K; Shimizu R
    Chem Biodivers; 2009 Nov; 6(11):1845-66. PubMed ID: 19937826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug permeability across a phospholipid vesicle based barrier: a novel approach for studying passive diffusion.
    Flaten GE; Dhanikula AB; Luthman K; Brandl M
    Eur J Pharm Sci; 2006 Jan; 27(1):80-90. PubMed ID: 16246536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parallel artificial membrane permeability assay (PAMPA) - Is it better than Caco-2 for human passive permeability prediction?
    Reis JM; Sinkó B; Serra CH
    Mini Rev Med Chem; 2010 Oct; 10(11):1071-6. PubMed ID: 21044031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caco-2 permeability of weakly basic drugs predicted with the double-sink PAMPA pKa(flux) method.
    Avdeef A; Artursson P; Neuhoff S; Lazorova L; Gråsjö J; Tavelin S
    Eur J Pharm Sci; 2005 Mar; 24(4):333-49. PubMed ID: 15734300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.